Is CoDon AG halal to invest in?

According to Musaffa's Shariah screening methodology, CoDon AG (CNW.F) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is CoDon AG a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes CoDon AG using these criteria to determine its compliance status.

Can Muslims buy shares of CoDon AG?

Muslim investors may consider investing in CoDon AG if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is CoDon AG classified as NOT COVERED?

Musaffa determines the Shariah status of CoDon AG by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for CoDon AG updated?

The Shariah compliance status of CoDon AG may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like CoDon AG become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of CoDon AG?

You can check the latest Shariah compliance status of CoDon AG on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

CoDon AG CNW.F

€0.01

Last Updated: May 12, 12:00 AM·XFRA

CoDon AG. Stock Analysis CNW.F

Germany Health Care Nano Cap

co.don AG engages in cell cultivation for the regenerative treatment of articular cartilage defects. The firm develops, produces, and distributes autologous cell therapies for the minimally invasive repair of cartilage defects, it manufactures cell-based biological drugs for the use in orthopedic and neurosurgical applications. Its products are used for the treatment of focal cartilage defects, lumbar disc herniation, non-union fractures, and dental disorders. Those include co don chondrotransplant, which is used for cartilage treatment, co don chondrosphere, which is a three-dimensional articular cartilage cultivated outside of the body; co don chondrotransplant DISC, for the regeneration of intervertebral discs, and co don osteotransplant DENT, which is an autologous bone cell transplant for dental applications. The company also offers biopsy, cultivation, transplantation, rehabilitation and others.

Key Statistics of CoDon AG (CNW.F)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€0.01€0.01

Today's Open

€0.01

Volume

15.00

P/E Ratio (TTM)

52 Week Range

€0.00€0.04

Market Cap

350.00K

Avg. Volume

178.69

Dividend Yield

Financial Metrics & Statements of CoDon AG (CNW.F)

FAQ's for CoDon AG (CNW.F)

According to Musaffa’s Shariah screening methodology, CoDon AG (CNW.F) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.